Avlani VA, Ma W, Mun H, Leach K, Delbridge L, Christopoulos A, Conigrave AD. Calcium-sensing receptor-dependent activation of CREB phosphorylation in HEK293 cells and human parathyroid cells. Am J Physiol Endocrinol Metab 304: E1097-E1104, 2013. First published March 26, 2013 doi:10.1152/ajpendo.00054.2013.-In addition to its acute effects on hormone secretion, epithelial transport, and shape change, the calcium-sensing receptor (CaSR) modulates the expression of genes that control cell survival, proliferation, and differentiation as well as the synthesis of peptide hormones and enzymes. In the present study, we investigated the impacts of a CaSR agonist and several CaSR modulators on phosphorylation of transcription factor CREB residue Ser 133 in CaSR-expressing HEK293 (HEKCaSR) cells and human adenomatous parathyroid cells. Elevated Ca 2ϩ o concentration had no effect on CREB phosphorylation (p-CREB) in control HEK293 cells but stimulated p-CREB in both HEK-CaSR cells and human parathyroid cells. In addition, p-CREB was stimulated by the positive modulator cinacalcet and inhibited by the negative modulator NPS 2143 in both CaSR-expressing cell types. Two positive modulators that bind in the receptor's Venus Fly Trap domain, L-phenylalanine and S-methylglutathione, had no effect on p-CREB in HEK-CaSR cells, demonstrating the existence of pronounced signaling bias. Analysis of the signaling pathways using specific inhibitors demonstrated that phosphoinositide-specific phospholipase C and conventional protein kinase C isoforms make major contributions to Ca 2ϩ o-induced p-CREB in both cell-types, suggesting key roles for G q/11. In addition, in parathyroid cells but not HEK-CaSR cells, activation of p-CREB was dependent on G i/o, demonstrating the existence of cell type-specific signaling. o and the type II calcimimetic cinacalcet stimulated rather than inhibited CREB phosphorylation in CaSR-expressing HEK293 (HEK-CaSR) cells as well as human parathyroid cells. In addition, the calcilytic NPS 2143 suppressed CREB phosphorylation in both cell types. We also characterized the signaling pathways by which the CaSR promotes p-CREB formation, identifying PI-PLC and PKC as key intermediates in both CaSR-expressing HEK293 cells and human parathyroid cells and G i/o and MEK, immediately upstream of ERK1/2, as additional control points in parathyroid cells.
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calcium-sensing receptor; CREB; ERK1/2; calcimimetic; calcilytic; cinacalcet; parathyroid THE EXTRACELLULAR CALCIUM-SENSING RECEPTOR (CaSR) is a widely expressed, pluripotent, class C G protein-coupled receptor that regulates whole body calcium metabolism via inhibitory control of parathyroid hormone (PTH) secretion and renal calcium reabsorption (reviewed in Ref. 5) , and acts as a nutrient sensor in the gastrointestinal tract (reviewed in Ref. 7) . In addition, it modulates cell survival, proliferation, and differentiation in diverse tissues, including bone and cartilage, epidermis, lung, CNS, and other tissues (reviewed in Ref. 36 ). These roles indicate that the receptor modulates gene expression in addition to mediating acute control of the cytoskeleton, vesicle trafficking, and transepithelial transport. The CaSR's principal physiological ligand, extracellular Ca 2ϩ (Ca 2ϩ o ), is an agonist with a broad spectrum of efficacy for multiple signaling pathways downstream of G q/11 , G i/o , and G 12/13 and even signals by transactivating other receptors including the epidermal growth factor receptor (reviewed in Refs. 3, 44) . Thus, the Ca (31, 43) , and synthetic compounds including the phenylalkylamine-positive modulators cinacalcet, NPS R-467, and NPS R-568 and negative modulator NPS 2143, all of which bind in the receptor's heptahelical (HH) domain (17, 28) .
We demonstrated recently that CaSR modulators, including the amino acid L-Phe and glutathione analogs such as Smethylglutathione (SMG), as well as elevated Ca 2ϩ o concentration, suppress cAMP levels in CaSR-expressing human embryonic kidney (HEK)293 cells (4) . In considering the possible implications of these findings for the control of gene expression, we tested the effect of elevated Ca 2ϩ o and other CaSR modulators on the phosphorylation of the transcription factor CREB at the key residue Ser 133 . Somewhat to our surprise, elevated Ca 2ϩ o and the type II calcimimetic cinacalcet stimulated rather than inhibited CREB phosphorylation in CaSR-expressing HEK293 (HEK-CaSR) cells as well as human parathyroid cells. In addition, the calcilytic NPS 2143 suppressed CREB phosphorylation in both cell types. We also characterized the signaling pathways by which the CaSR promotes p-CREB formation, identifying PI-PLC and PKC as key intermediates in both CaSR-expressing HEK293 cells and human parathyroid cells and G i/o and MEK, immediately upstream of ERK1/2, as additional control points in parathyroid cells.
MATERIALS AND METHODS
Cell culture. HEK293 cells stably expressing the human CaSR (HEK-CaSR cells) and untransfected HEK293 cells were cultured in DMEM (Invitrogen) supplemented with 10% fetal bovine serum (FBS) as described previously (4) . In general, cultured cells were studied between passages 3 and 20.
Preparation of human parathyroid cells. Samples of adenomatous human parathyroid tissue were obtained from patients undergoing surgery for primary hyperparathyroidism at the Royal North Shore Hospital and North Shore Private Hospital, St Leonards, New South Wales, as well as the Mater Misericordiae Hospital, North Sydney, New South Wales, Australia. All procedures were performed under guidelines established by the relevant human research ethics committees, and all patients provided written informed consent for the use of the tissue for experimental purposes.
Parathyroid tissue was transported to the laboratory in MEM (1.25 mM CaCl 2). Upon arrival in the laboratory, it was either used immediately or, more typically, stored overnight in MEM at 4°C, a condition under which parathyroid tissue retains viability (11) . The method for collagenase-dependent release of parathyroid cell clumps from ϳ1-mm cubes of adenomatous parathyroid tissue followed closely that described in Ref. 11, including 20-min incubations at 37°C in 5-ml lots of preoxygenated MEM containing Worthington type I collagenase (1 mg/ml, Scimar Victoria) and DNase I type IV (0.2 mg/ml, Sigma) followed by trituration (10 -15 times) through the tip of a disposable 5-ml syringe (no needle attached), passage through a nylon filter (pore size 200 m), sedimentation in a bench top centrifuge (70 g, 2.5 min), and resuspension in 5 ml of 1 mg/ml BSA-containing MEM. The cell pellet was then washed twice by centrifugation and finally resuspended in 2 ml of bovine serum albumin-containing MEM. The parathyroid cell clumps obtained in this way typically contained 10 -100 cells.
Measurement of phospho-CREB and phospho-ERK1/2. Phospho-CREB (Ser 133 ) and phospho-ERK1/2 (Thr 202 /Tyr 204 ) levels were estimated using SureFire AlphaScreen assay kits (PerkinElmer). Both are proximity-based assays in which two distinct bead populations are covalently linked to two distinct antibodies, one of which binds to a constant epitope on the target protein and the other of which binds to the protein's phospho-epitope. Physical approximation of two beads by antibody-based interactions with proteins phosphorylated on their respective epitopes is detected by light-induced singlet oxygen release from one bead followed by the release of light of a second wavelength from the second bead.
In the cases of CaSR-expressing HEK293 cells or control HEK293 cells, cells that had been released from flasks by trypsinization and then washed and resuspended in 10% FBS-containing DMEM (Invitrogen) were pipetted into poly-D-lysine-coated 96-well plates at a density of 50,000 cells per well and incubated for 4 -6 h at 37°C in a humidified incubator (5% CO2). The cells were then serum starved overnight in DMEM containing 1.5 mM Ca 2ϩ and 0.2% BSA. The following morning, the serum starvation medium was removed, and the wells were washed once with 0.2-ml samples of HEPES-buffered physiological saline solution (PSS; 125 mM NaCl, 4 mM KCl, 20 mM HHEPES, 1 mM MgCl2, and 0.1% D-glucose, pH 7.4; adjusted with NaOH) that contained 0.2 mM Ca 2ϩ and then filled with 0.2 ml of fresh PSS (0.2 mM Ca 2ϩ ). The plates were preincubated for 30 min at 37°C in a humidified incubator (5% CO2), and the wells were then exposed to various Ca 2ϩ o concentrations in the absence or presence of CaSR modulators for various time intervals at 37°C. Vehicle-only controls were performed as required. Upon completion of the incubations, the PSS was removed, and the wells were filled with Alpha Screen Lysis Buffer. The kit protocols were then followed for phospho-CREB (p-CREB) or phospho-ERK1/2 (p-ERK1/2) according to the manufacturer's instructions. The Alpha Screen signals were quantified for each plate using a PerkinElmer Envision Multilabel counter.
For assays of ERK1/2 and CREB phosphorylation in adenomatous human parathyroid cells, cell pellets obtained using collagenase digestion as described above were transferred to serum-free MEM (1.25 mM Ca 2ϩ o) and cultured overnight in 96-well plates (60 -70% confluence) at 37°C in a humidified incubator (5% CO2). The following day, the culture medium was removed and replaced with PSS containing 0.2 mM Ca 2ϩ o, and the experiments were performed as described above for HEK-CaSR cells.
Data analysis. The data are expressed routinely as means Ϯ SE. Numbers of independent experiments are provided in the figure legends. Statistical comparisons between treatments were performed using ANOVA and/or unpaired t-tests (GraphPad Prism version 5B for Macintosh). Statistically significant comparisons were accepted at P Ͻ 0.05.
Concentration-response data were plotted using GraphPad Prism (version 5B for Macintosh), and curve fitting was performed using the following form of the Hill equation: R ϭ b ϩ (a Ϫ b) C n /(e n ϩ C n ), where R ϭ response, a ϭ maximum response, b ϭ basal response, C ϭ extracellular Ca 2ϩ concentration (in mM), e ϭ EC50 (the Ca 2ϩ o concentration that induced a half-maximal response) and n ϭ Hill coefficient. (Fig. 1A) , whereas HEK-CaSR cells exhibited a rapid initial rise in p-CREB over 5-10 min that reached a maximum three-to fourfold level by 30 min followed by a slow decline to ϳ70 -80% of the maximum response at 60 min (Fig. 1B) .
RESULTS
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We next determined the Ca Fig. 2A and Table 1 ). However, cinacalcet had no effect on the maximum Ca Table 1 ). The data demonstrate that positive and negative allosteric modulators that bind in the receptor's HH domain differentially modulate Ca 
-induced CREB phosphorylation in HEK-CaSR cells was dependent on PI-PLC and PKC but not G i/o or ERK1/2.
Since CREB can be phosphorylated at Ser 133 by several distinct protein kinases in a cell type-specific manner, we next investigated the signaling pathway(s) that supports CaSR-mediated p-CREB in HEK-CaSR cells, using specific inhibitors and compared results for CaSR-mediated p-ERK1/2 ( Fig. 4A ) and p-CREB (Fig. 4B) . First, HEK-CaSR cells were preincubated for 15 min in the absence or presence of the PI-PLC inhibitor U73122 or PKC inhibitor GF-109203X and then exposed to high Ca fects of U73122 alone (not shown), suggesting that in both cases the inhibitors act on a common intracellular signaling pathway, e.g., in which PI-PLC couples to PKC. Unlike U73122, its analog U73343, which is inactive with respect to PI-PLC, had no effect at the concentration tested (5 M; three experiments; not shown).
The CaSR stimulates p-ERK1/2, dependent in part on PI-PLC/PKC and G i/o (22) . In addition, in some cell types, p-ERK1/2 is reported to induce CREB phosphorylation at (Fig. 4A) . However, PTX pretreatment had no effect on high Ca 2ϩ o -induced p-CREB (Fig. 4B) . Similarly, PD-98059 (50 M) significantly inhibited Ca 2ϩ oinduced p-ERK1/2 by ϳ80% (Fig. 4A ) but had no effect on high Ca 2ϩ o -induced p-CREB in HEK-CaSR cells (Fig. 4B) . The results indicate that neither G i/o nor p-ERK1/2 is involved in the Ca (Fig. 4A) , the inhibitory effect of GF-109203X on p-CREB was not enhanced by PTX pretreatment (Fig. 4B) . The inhibitor studies suggest the existence of distinct signaling pathways for Ca (Fig. 5A ). In addition, 3 mM Ca 2ϩ o stimulated CREB phosphorylation, reaching a peak twofold elevation relative to baseline at 30 min, followed by a gradual decline to ϳ60% of the peak after 60 min (Fig. 5B) .
We also tested the effects of the positive modulator cinacalcet and negative modulator NPS 2143 on CaSR mediated p-ERK1/2 and p-CREB at 30-min incubation. Due to variations in the levels of p-ERK1/2 and p-CREB between batches of cells prepared from tumor samples from different patients, the data were expressed as normalized percentages with respect to the levels obtained at low Ca (Fig. 6 ). Cinacalcet (2 M) significantly promoted p-ERK1/2 (Fig. 6A ) and p-CREB (Fig. 6B) 
CaSR-mediated p-CREB is dependent on PI-PLC, PKC, and G i/o in human parathyroid cells.
Finally, to define key elements of the signaling pathway by which the CaSR mediates ERK1/2 and CREB phosphorylation in human parathyroid cells, experiments were performed to investigate the roles of G i/o (300 ng/ml PTX), PI-PLC (5 M U73122), PKC conventional isoforms (1 M GF-109203X) or, immediately upstream of ERK1/2, MEK (50 M PD-95089).
With respect to 2 mM Ca 2ϩ o -induced elevations in p-ERK1/2, we observed significant inhibitions in response to PTX pretreatment (by ϳ35%), U73122 (by ϳ75%), GF-109203X (by ϳ35%), and PD-98059 (by ϳ95%; Fig. 7A ), the latter consistent with a tight dependence of ERK1/2 phosphorylation on MEK activity. We investigated the apparent requirement of p-ERK1/2 for both G q/11 and G i/o in parathyroid cells by testing the impact of U73122 (PI-PLC inhibitor) following PTX pretreatment. In PTX-treated cells, U73122 suppressed ERK1/2 phosphorylation by ϳ85% with respect to control untreated cells. However, the effect was not significantly different from that of U73122 in untreated cells (P Ͼ 0.5).
With respect to 2 mM Ca 2ϩ o -induced elevations in p-CREB, we observed inhibitory effects for U73122 (by ϳ60%) and GF-109203X (by ϳ70%), as expected from the findings in HEK-CaSR cells. Surprisingly, however, and distinct from the findings in HEK-CaSR cells, p-CREB in parathyroid cells was also inhibited following PTX pretreatment (by ϳ40%) or the MEK inhibitor PD-98059 (by ϳ85%; Fig. 7B ). Furthermore, in PTX-treated cells, U73122 (5 M) nearly abolished high Ca 2ϩ o -induced p-CREB (Fig. 7B) . 
DISCUSSION
The CaSR is expressed widely in endocrine, epithelial, neuronal, and mesenchymal tissues with versatile tissue-specific roles that depend in part on the compositions of the compartments to which it is exposed and the cell-specific signaling pathways to which it couples. In general, it acts by coopting three different sets of heterotrimeric G proteins: G q/11 , G i/o , and G 12/13 . Thus, in diverse cell types, but perhaps not all, the CaSR activates PI-PLC and PKC and mobilizes Ca 2ϩ ions, suppresses cAMP levels, and activates Rho kinase and PLD (3, 26) . With respect to whole body calcium metabolism, the CaSR provides protection from hypercalcemia by 1) suppressing renal calcium reabsorption and 2) suppressing bone resorption directly via receptors on osteoclasts and indirectly via enhanced calcitonin secretion from thyroid C cells (reviewed in Refs. 5, 36) . It also mediates Ca synthesis and secretion and modulates parathyroid cell proliferation (reviewed in Refs. 5, 6) .
In addition to mediating acute effects on hormone secretion, transepithelial transport, cell shape, and bone resorption, the CaSR modulates cell survival, proliferation, and differentiation. Thus, it positively modulates osteoblast and chondrocyte cell number and differentiation (reviewed in Ref. 38 ) and promotes keratinocyte differentiation (42) . These effects arise, at least in part, from CaSR-mediated transcriptional modulation of gene expression. However, in many cases, the molecular mechanisms by which the CaSR modulates gene expression and the identities of the genes it controls are unknown. Transcription factors that are reported to be under CaSR control include ERK1/2-dependent factors such as c-Jun, cFos, Elk-1, and Egr-1 (39), and serum response factor (33) . These transcription factors have well-defined roles in the control of cell proliferation and differentiation, and the pathways that link CaSR stimulation to their activation have been defined, at least in part, in HEK293 cells (39) . Recently, a CaSR signaling pathway that controls the expression of regulatory microRNAs has also been identified (18) .
The phosphoprotein CREB is a key transcription factor, which modulates gene expression by binding to so-called cAMP response elements (CREs) in diverse promoters. Although CREB is classically activated via cAMP and its downstream protein kinase PKA, and the CaSR typically suppresses rather than activates this pathway, CREB is phosphorylated and activated by several other protein kinases, including PKC isoforms, ERK1/2, and CaM kinase-II (reviewed in Refs. 1, 27) . In many of these cases, phosphorylation occurs on a common residue, Ser 133 , together with additional sites that are necessary for CREB-dependent transcriptional activation (reviewed in Refs. 1, 21) . CREB modulates a large number of target genes, including genes that control growth and differentiation. In the present study, we investigated the impact of CaSR activation on phosphorylation of the key CREB residue Ser 133 using untransfected HEK293 cells, HEK293 cells that stably express the calcium-sensing receptor (HEK-CaSR) cells, and human adenomatous parathyroid cells, which express the CaSR endogenously. The results demonstrate that Ca The adenylyl cyclase activator forskolin (10 M) induced similar time-dependent increases in CREB phosphorylation in both untransfected HEK293 cells and HEK-CaSR cells, demonstrating that the PKA-dependent pathway for CREB phosphorylation was intact and operating in a similar manner in both cell types regardless of CaSR expression. As noted above, and distinct from the action of forskolin, activation of the CaSR in HEK-CaSR cells suppresses rather than elevates intracellular cAMP levels (4, 16) , indicating the operation of two distinct signaling pathways to CREB phosphorylation following Ca 2ϩ o -induced CaSR activation on the one hand and forskolin-induced elevations in cAMP on the other.
To investigate the signaling basis of CaSR-mediated CREB phosphorylation, we tested the effects of various inhibitors of known signaling pathways downstream of the CaSR, including PTX pretreatment to uncouple G i/o signaling, U73122 to inhibit PI-PLC, GF-109203X to inhibit conventional PKC isoforms, and PD-98059 to inhibit MEK immediately upstream of ERK1/2. The results of these experiments demonstrate that PI-PLC downstream of G q/11 , and PKC but not G i/o or ERK1/2, are required for CaSR-mediated phosphorylation of CREB in HEK293 cells (Fig. 4B) . In contrast, CaSR-mediated activation of ERK1/2 was partially suppressed by around 50 -90% by all four agents, indicating roles for both the G q/11 and G i/o pathways, as described previously (22) . Thus, the CaSR-mediated signaling pathways for the activation of ERK1/2 and CREB phosphorylation are clearly distinct in HEK293 cells and presumably other cell types. In a recent report, however, an NPS R-568-stimulated CaSR-mediated survival pathway involving p90 RSK and p-CREB downstream of ERK1/2 was demonstrated in glomerular podocytes (32) . CaSR-dependent signaling pathways are sensitive to the phenylalkylamine-positive and -negative modulators cinacalcet and NPS 2143, respectively, which bind in the receptor's HH domain (28) , as well as the aromatic amino acid L-Phe and glutathione analog SMG, which bind in the receptor's NH 2 -terminal VFT domain (31, 43) . Interestingly, biased signaling arises from distinct ligand-bound conformations of the CaSR so that signaling pathways are sensitive to the actions of some but not all modulators (14, 24, 40) . Furthermore, some modulators have little or no effect on some signaling pathways. Striking examples of this latter phenomenon include CaSRmediated PI-PLC (35) , which was reported to be insensitive and ERK1/2 phosphorylation (25), which was reported to exhibit only a small fine-tuning response to L-Phe. In the present study, we found that cinacalcet positively modulated and NPS 2143 negatively modulated p-CREB, respectively, consistent with their actions on diverse CaSR-dependent signaling pathways. However, L-Phe and SMG had no effect on p-CREB in HEK-CaSR cells at concentrations that were near maximal with respect to Ca 2ϩ i mobilization or suppression of intracellular cAMP levels (4, 12) . The basis for the difference in signaling bias in response to VFT modulators on the one hand and HH domain modulators on the other is not clear but suggests the existence of a fundamental difference in the underlying mechanisms of receptor activation and raises the possibility that Ca 2ϩ o binding in the VFT (19, 20) and HH (34) domains may also have differential signaling effects. Consistent with this notion, recent work has demonstrated the existence of signaling bias for multivalent cation-dependent activation of the CaSR in HEK293 cells (40) and calcitoninsecreting rat 6-23 medullary thyroid carcinoma cells (41) .
To investigate the physiological significance of the observations on HEK-CaSR cells, we also determined the impact of elevated Ca (29, 30) . In addition, as for HEK-CaSR cells, we observed CaSR-dependent CREB phosphorylation in human adenomatous parathyroid cells that was activated by elevated Ca 2ϩ o concentration (Fig. 5) , positively modulated by cinacalcet (Fig.  6 ), and negatively modulated by NPS 2143 (Fig. 6) . Although the time course of CREB activation is slow compared with the acute rates of change in PTH secretion that arise from acute changes in Ca 2ϩ o concentration (11; reviewed in Ref. 8) , the results are consistent with the hypothesis that CREB might modulate signaling pathways for the control of PTH synthesis or cell fate and/or cell number via changes in gene expression. One interesting candidate gene is CYP27B1, which is expressed in parathyroid cells, controls the local synthesis of the key modulator 1,25-dihydroxyvitamin D, and thereby contributes to Ca 2ϩ o -dependent suppression of preproPTH synthesis (37) . The CYP27B1 promoter includes two CRE sites as well as other regulatory elements that might be under CaSR control (15) .
We also investigated the signaling pathway(s) involved in CaSR-mediated CREB and ERK1/2 phosphorylation in parathyroid cells and compared the results with the studies of ostimulated p-ERK1/2 and p-CREB in HEK-CaSR cells. However, the signaling pathway from the CaSR to CREB phosphorylation differed in one important respect in parathyroid cells compared with HEK-CaSR cells: it was impaired by overnight PTX treatment, indicating that the pathway in parathyroid cells is dependent, at least in part, on the activation of G i/o . Thus, the results indicate that CaSR-mediated p-CREB is dependent primarily on a G q/11 -mediated pathway in HEKCaSR cells and on both G q/11 and G i/o in parathyroid cells. In addition, the results indicate that, unlike HEK-CaSR cells, activation of p-CREB in parathyroid cells is partly dependent on p-ERK1/2, suggesting the existence of a G i/o /p-ERK pathway upstream of p-CREB.
In conclusion, we find that Ca 
